Duragen (203001) was returned for evaluation: failure analysis - the duragen sample received back had 1 tray containing 1 y-connector, 3 spray tips, 1 syringe holder and 1 plunger cap, 2 syringes (1 blue syringe and 1 clear syringe), and 1 vial.The y-connector, 3 spray tips, 1 syringe holder, and 1 plunger cap were all found clean with no traces of blue solution.The clear syringe was returned with 1.5 ml of solution, no signs of use were observed.The blue syringe was returned empty with traces of dry solution close to the tip.The vial was returned with the bioset fully depressed, no red line was visible.Traces of blue solution were observed on top of the bioset and inside the vial.Following sample evaluation, the reported failure mode could not be confirmed because the blue syringe was observed empty with dry solution inside and the vial was observed with traces of blue solution, meaning the peg had been reconstituted.The content of each syringe should be 1.5 ml; with the blue syringe returned empty, the volume of the blue syringe could not be confirmed.Root cause -the root cause is undetermined and the complaint was unable to be confirmed with the information available.A dhr review and trending were performed as part of the evaluation.Proper finished good testing was performed prior to release as indicated in the dhr.Product was received was tested and no issues where found nor could the complaint be replicated.Per the dfmea, potential causes of failure include: performance, adhesion barrier.The risk remains acceptable per the risk analysis.
|